YBX1 and hepatocellular carcinoma: LINC00618 regulates cholesterol metabolism in liver cancer cells through the ubiquitin-protease-NSUN2-YBX1-SREBP2 axis, ultimately promoting the growth and metastasis of HCC (Li R. et al., 2024).